The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.
September 27th 2024
Out-of-pocket costs for biosimilars and generics are still high for patients despite these drugs leading to estimated savings of $445 billion in 2023.
Dr Elaine Husni: Huge Savings With Biosimilars Have Not Manifested
Dr Ali McBride Discusses the Role of Biosimilars in Oncology